Cite
HARVARD Citation
Tawbi, H. et al. (2021). Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204). Neuro-oncology. 23 (11), pp. 1961-1973. [Online].